Skip to main content

How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS

By: 3BL Media

By Kate Morgan

SOURCE: Johnson & Johnson

SUMMARY:

On the 40th anniversary of what would become the first AIDS diagnosis, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.

DESCRIPTION:

Forty years ago, in June 1981, a mysterious disease emerged in California and New York. It would soon become one of the most well-known—and urgent—health challenges of our time.

Today, there are some 38 million people in the world living with human immunodeficiency virus (HIV). Each year, 1.7 million more are newly infected with the virus.

Continue reading here

Tweet me: On the 40th anniversary of what would become the first AIDS diagnosis, @JNJNews looks at the groundbreaking strides the company has made—and continues to make. https://bit.ly/2XMObVH

KEYWORDS: NYSE: JNJ, johnson & johnson, HIV/AIDS

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.67
+4.52 (2.25%)
AAPL  265.43
+1.55 (0.59%)
AMD  201.91
-1.17 (-0.57%)
BAC  53.34
+0.60 (1.14%)
GOOG  304.80
+1.98 (0.65%)
META  641.04
+1.75 (0.27%)
MSFT  401.21
+4.35 (1.10%)
NVDA  188.99
+4.02 (2.17%)
ORCL  156.40
+2.43 (1.57%)
TSLA  413.61
+2.98 (0.73%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.